SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-031715
Filing Date
2018-05-09
Accepted
2018-05-09 16:09:26
Documents
42
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8675_110q.htm 10-Q 469361
2 EX-10.1 a18-8675_1ex10d1.htm EX-10.1 9005
3 EX-31.1 a18-8675_1ex31d1.htm EX-31.1 10741
4 EX-31.2 a18-8675_1ex31d2.htm EX-31.2 10747
5 EX-32.1 a18-8675_1ex32d1.htm EX-32.1 7046
12 GRAPHIC g86751bai001.jpg GRAPHIC 1599
  Complete submission text file 0001104659-18-031715.txt   2206788

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rarx-20180331.xml EX-101.INS 428603
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rarx-20180331.xsd EX-101.SCH 20999
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rarx-20180331_cal.xml EX-101.CAL 28160
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rarx-20180331_def.xml EX-101.DEF 51162
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rarx-20180331_lab.xml EX-101.LAB 196101
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rarx-20180331_pre.xml EX-101.PRE 127865
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37926 | Film No.: 18818326
SIC: 2834 Pharmaceutical Preparations